Insider filing · COGT
Jessica Sachs
Chief Medical Officer
profile →
Cogent Biosciences, Inc.
COGT · Healthcare · 9 filings in 24 months
ticker →
Jessica Sachs sold $3.2M of Cogent Biosciences (COGT)
Executed Dec 26 2025, disclosed Dec 30 2025, 4 days later.
Value, as filed
$3.2M
82,642 sh × $38.70
Executed
Dec 26 2025
the trade date, as filed
Disclosed
Dec 30 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JSJessica Sachs (Chief Medical Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Cogent Biosciences, Inc. (COGT). The largest single filing was $3.2M of COGT (82,642 sh × $38.70, as filed), executed Dec 26 2025.
The name
COGTHealthcare · Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→